Skip to content

Sustained Lung Inflation in Preterm Infants

Effect of Application of Sustained Lung Inflation on the Respiratory Outcome of Preterm Infants With Respiratory Distress Syndrome

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03518762
Enrollment
160
Registered
2018-05-08
Start date
2014-12-21
Completion date
2017-09-05
Last updated
2020-06-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Preterm Infant

Brief summary

This is a randomized controlled study to investigate the effect of application of sustained lung inflation (SLI) at birth on the respiratory outcome of preterm infants with respiratory distress syndrome.

Detailed description

Enrolled infants (n=160) were randomized before birth into 2 groups (intervention and control group) in a ratio 1:1. Randomization was done through an online randomizer (www.graphpad.com), and sealed envelopes were used to assign the infant to one of the two groups.

Interventions

PROCEDURESustained lung inflation (SLI)

SLI was given using a peak pressure of 20 cm H₂O sustained for 15 seconds,using a T-piece resuscitator, Neopuff device

PROCEDUREContinuous positive airway pressure (CPAP)

CPAP through an appropriate mask using a pressure 5 cm H₂O,using a T-piece resuscitator, Neopuff device.

Sponsors

Kasr El Aini Hospital
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Caregiver)

Eligibility

Sex/Gender
ALL
Age
No minimum to 1 Minutes
Healthy volunteers
No

Inclusion criteria

* Gestational age ≥ 27 weeks and ≤ 32 weeks * Appropriate for gestational age * Weight \>800 grams

Exclusion criteria

* Major congenital anomalies (congenital heart, cerebral, lung or abdominal malformations) * Fetal hydrops

Design outcomes

Primary

MeasureTime frameDescription
Need for invasive mechanical ventilation or deathFrom birth up to 72 hours of lifeTreatment failure; defined as the need for intubation and invasive mechanical ventilation or death

Secondary

MeasureTime frameDescription
Duration of invasive mechanical ventilationFrom date of birth until the date of discharge home or death from any cause, whichever came first, assessed upto 100 daysThe duration of intubation and invasive mechanical ventilation (in days)
PneumothoraxFrom date of birth until the date of discharge home or death from any cause, whichever came first, assessed upto 100 daysPneumothorax, documented by radiological findings
Bronchopulmonary dysplasiaAssessed at 36 weeks postmenstrual age or discharge, whichever came firstBronchopulmonary dysplasia, defined as the need for more than 21% oxygen for at least 28 days

Countries

Egypt

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 17, 2026